Updated:
Heal Capital
Berlin-based healthcare investment firm targeting European digital health and care delivery companies across venture and buyout stages.
Heal Capital
Heal Capital operates as a Berlin-based private equity and venture firm focused exclusively on European healthcare. The firm deploys across early-stage, growth, and buyout opportunities, targeting companies where technology reconfigures how care is paid for and delivered. Its investment scope spans digital health platforms, tech-enabled healthcare services, and health IT infrastructure. The firm runs a concentrated strategy that moves across the capital structure, making seed and start-up bets alongside control-oriented growth and buyout deals. This hybrid approach lets Heal Capital back clinical software companies at formation and later supply the expansion capital those same businesses need to scale across Europe's fragmented reimbursement systems. The geographic footprint concentrates on Germany, Austria, and Switzerland, with selective exposure to the Benelux and Nordic regions. Heal Capital maintains a deliberately low public profile. The firm does not disclose assets under management or detailed team composition, and its website provides minimal operational detail. This posture is consistent with a manager that sources through clinical networks and payer relationships rather than broad marketing. Structurally, Heal Capital differs from generalist European VC firms by operating as a dedicated healthcare investor that deploys across both venture and buyout stages. The single-sector mandate, combined with flexible check sizes, creates a sourcing model built on regulatory and reimbursement expertise that generalist firms cannot replicate.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Germany
City
Berlin
Corporate office
Berlin, Germany
Sector focus
Frequently asked questions
What investment stages does Heal Capital target?
Heal Capital invests across seed, start-up, growth, and buyout stages. The firm's flexible mandate allows it to back healthcare companies at formation and later provide expansion capital or pursue control investments. This multi-stage approach is unusual among dedicated healthcare investors.
Which healthcare sub-sectors does Heal Capital focus on?
The firm concentrates on digital health platforms, tech-enabled healthcare services, and health IT infrastructure. Its thesis centers on companies that create clinical pathways which integrate with payer reimbursement systems, rather than pure consumer health apps or biotech.
What is Heal Capital's geographic focus?
Heal Capital invests primarily in Germany, Austria, and Switzerland, with selective exposure to Benelux and Nordic markets. The firm's focus on Europe's regulated reimbursement systems shapes this geographic concentration.
How does Heal Capital source its investments?
The firm sources through clinical networks and payer relationships rather than broad marketing. Heal Capital maintains a deliberately low public profile, consistent with a manager that relies on domain-specific relationships within European healthcare systems.
Is Heal Capital a venture capital firm or a private equity firm?
Heal Capital operates as both. The firm makes venture-stage investments in seed and start-up companies while also pursuing growth equity and buyout transactions. This hybrid structure allows it to support healthcare businesses across their entire lifecycle.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: